Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Jacobson

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
The New England Journal of Medicine|May 22, 1997
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupJ M Jacobson, J S Greenspan, J Spritzler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 14, 1997
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trialF M Hecht, J Wheat, A H Korzun, et al.
The Journal of Infectious Diseases|June 3, 1999
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials GroupJ M Jacobson, J Spritzler, L Fox, et al.
AIDS Care|July 7, 2023
Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment eraJ Ma, B Luu, S A Ruderman, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
The New England Journal of Medicine|May 22, 1997
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupJ M Jacobson, J S Greenspan, J Spritzler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 14, 1997
Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trialF M Hecht, J Wheat, A H Korzun, et al.
The Journal of Infectious Diseases|June 3, 1999
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials GroupJ M Jacobson, J Spritzler, L Fox, et al.
AIDS Care|July 7, 2023
Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment eraJ Ma, B Luu, S A Ruderman, et al.
Pageof 6